-
EP4249060
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4249060
| EP4249060 - LIQUID PHARMACEUTICAL COMPOSITION OF ADALIMUMAB [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 05.07.2024 Database last updated on 18.11.2024 | |
| Former | The application has been published Status updated on 25.08.2023 | Most recent event Tooltip | 05.07.2024 | The date on which the examining division becomes responsible, has been established | 05.07.2024 | Request for examination filed | published on 07.08.2024 [2024/32] | 05.07.2024 | Change - designated states | published on 07.08.2024 [2024/32] | Applicant(s) | For all designated states Fresenius Kabi Deutschland GmbH Else-Kröner-Strasse 1 61352 Bad Homburg / DE | [2023/39] | Inventor(s) | 01 /
RINALDI, Gianluca I-00015 Monterotondo / IT | 02 /
FRATARCANGELI, Silvia I-03024 Ceprano / IT | 03 /
DEL RIO, Alessandra I-00144 Roma / IT | [2023/39] | Representative(s) | HGF HGF Limited 1 City Walk Leeds LS11 9DX / GB | [2023/39] | Application number, filing date | 23189888.3 | 15.05.2015 | [2023/39] | Priority number, date | EP20140169754 | 23.05.2014 Original published format: EP 14169754 | [2023/39] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP4249060 | Date: | 27.09.2023 | Language: | EN | [2023/39] | Type: | A3 Search report | No.: | EP4249060 | Date: | 03.01.2024 | Language: | EN | [2024/01] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 30.11.2023 | Classification | IPC: | A61K9/00, A61K38/00, A61K47/18, A61K47/26, A61K47/02, A61P1/00, A61P1/04, A61P17/06, A61P19/02, A61P19/00, A61P7/00, A61P19/08, A61P27/14, A61P29/00, A61P37/06, C07K16/24 | [2024/01] | CPC: |
A61K39/39591 (EP,CN,IL,US);
A61K9/0019 (EP,CN,IL,US);
A61K9/00 (DK,IL);
A61K38/00 (DK,IL);
A61K47/02 (EP,IL);
A61K47/183 (EP,CN,IL,US);
A61K47/26 (EP,CN,DK,IL,US);
A61K9/08 (CN,IL);
A61P1/00 (EP,IL);
A61P1/04 (EP,IL);
A61P17/06 (EP,IL);
A61P19/00 (EP,IL);
A61P19/02 (EP,IL);
A61P19/08 (EP,IL);
A61P27/14 (EP,IL);
A61P29/00 (EP,IL);
A61P37/06 (EP,IL);
A61P7/00 (EP,IL);
|
| Former IPC [2023/39] | A61P29/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2024/32] |
| Former [2023/39] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Title | German: | FLÜSSIGE PHARMAZEUTISCHE ZUSAMMENSETZUNG VON ADALIMUMAB | [2023/39] | English: | LIQUID PHARMACEUTICAL COMPOSITION OF ADALIMUMAB | [2023/39] | French: | COMPOSITION PHARMACEUTIQUE LIQUIDE DE L'ADALIMUMAB | [2023/39] | Examination procedure | 28.06.2024 | Amendment by applicant (claims and/or description) | 28.06.2024 | Examination requested [2024/32] | 28.06.2024 | Date on which the examining division has become responsible | Parent application(s) Tooltip | EP15724974.9 / EP3148510 | EP18169979.4 / EP3403646 | EP19215036.5 / EP3659582 | Fees paid | Renewal fee | 04.08.2023 | Renewal fee patent year 03 | 04.08.2023 | Renewal fee patent year 04 | 04.08.2023 | Renewal fee patent year 05 | 04.08.2023 | Renewal fee patent year 06 | 04.08.2023 | Renewal fee patent year 07 | 04.08.2023 | Renewal fee patent year 08 | 04.08.2023 | Renewal fee patent year 09 | 16.05.2024 | Renewal fee patent year 10 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]WO2011104381 (NOVO NORDISK AS [DK], et al); | [Y]WO2013186230 (BOEHRINGER INGELHEIM INT [DE]); | [Y]WO2014039903 (COHERUS BIOSCIENCES INC [US]) | by applicant | WO9729131 |